Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum IMV Inc IMVIF

IMV Inc. is a Canada-based company. The Company has no business operations.

GREY:IMVIF - Post Discussion

IMV Inc > IMV scientific report
View:
Post by Jthom376 on Mar 10, 2021 2:37pm

IMV scientific report

Anyone have any thoughts on this? Hadn't noticed it until today.


https://www.nature.com/articles/s41598-021-82108-4

Comment by qwerty22 on Mar 11, 2021 1:29pm
It's really just science. Maybe describe it as pre-preclinical. The importance to me is in relation to the dlbcl/pd-l1 finding. What this paper talks about is the importance of immune suppressors in tumours. These are a bunch of mechanisms that stop the immune system from targeting and killing tumour cells. PS is the mechanism they look at in this Nature paper. What they show is if you ...more  
Comment by Jthom376 on Mar 11, 2021 6:21pm
Thanks Q - it was above me... appreciate the nreak down. I initially got fixated on the anti inflammatory remarks noted but struggled to understand any of it. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities